Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-03-09 @ 7:04 AM
Study NCT ID:
NCT00362960
Status:
COMPLETED
Last Update Posted:
2006-10-09
First Post:
2006-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olmesartan Medoxomil and Diabetic Nephropathy
Sponsor:
Sankyo Pharma Gmbh
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SE-866/29
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None